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S U M M A R Y
Objectives: A large cluster of the Middle East respiratory syndrome (MERS) linked to healthcare setting
occurred from May to July 2015 in the Republic of Korea. The present study aimed to estimate the case
fatality ratio (CFR) by appropriately taking into account the time delay from illness onset to death. We
then compare our estimate against previously published values of the CFR for MERS, i.e., 20% and 40%.
Methods: Dates of illness onset and death of the MERS outbreak in the Republic of Korea were extracted
from secondary data sources. Using the known distribution of time from illness onset to death and an
integral equation model, we estimated the delay-adjusted risk of MERS death for the South Korean
cluster.
Results: Our most up-to-date estimate of CFR for the MERS outbreak in South Korea was estimated at
20.0% (95% conﬁdence intervals (CI): 14.6, 26.2). During the course of the outbreak, estimate of the CFR in
real time appeared to have decreased and become signiﬁcantly lower than 40%.
Conclusions: The risk of MERS death in Korea was consistent with published CFR. The estimate decreased
with time perhaps due to time-dependent increase in case ascertainment. Crude ratio of cumulative
deaths to cases underestimates the actual risk of MERS death because of time delay from illness onset to
death.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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A cluster of the Middle East respiratory syndrome (MERS) was
observed from May to July 2015 in the Republic of Korea. More
than 14,000 contacts had to be traced for monitoring.1 As of 31st
July 2015, there have been a total of 185 conﬁrmed cases and
36 deaths reported from this cluster.2
To assess the clinical seriousness of an infection, it is vital to
estimate the case fatality ratio (CFR), the proportion of deaths
among cases. The real-time estimation involves two epidemiologi-
cal biases. A well-known issue during the course of an epidemic is
right censoring; i.e., many of cases have not passed through the* Corresponding author. Graduate School of Medicine, The University of Tokyo,
7-3-1 Hongo, Bunkyo-ku, Tokyo 1130033, Japan. Tel.: +81 3 5841 3688;
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).time required for themselves to die, and thus, the crude ratio of the
cumulative numbers of deaths to cases could underestimate the
CFR.3–5 Another issue for the estimation of CFR is the ascertain-
ment bias; i.e., the reported cases may not represent a substantial
part of the total number of infections, and thus, the ratio of
conﬁrmed deaths to cases may overestimate the actual risk of
death that might be perceived as the risk among all infected
individuals.6,7 So far, the CFR among diagnosed cases for MERS is
40%,8 but that among secondary cases may be around 20%.9
The purpose of the present study is to estimate the CFR for
MERS in the Republic of Korea by accounting for the time-delay
from illness onset to death and comparing the estimate against
published values.
2. Materials and Methods
Our analysis rests on secondary data concerning the number of
conﬁrmed cases and deaths of MERS in the Republic of Korea.10–13ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Figure 2. The risk of death caused by Middle East respiratory syndrome coronavirus
(MERS-CoV) in the Republic of Korea, 2015.
Estimated case fatality ratio (CFR) as a function of calendar time. The two horizontal
dashed grey lines represent published values of CFR, i.e., 20% and 40% [8,9]. The
crude ratio is calculated as the ratio of cumulative numbers of deaths to cases,
which likely underestimates the risk of death and may increase over the course of
calendar time. The whiskers of estimated CFR extend to lower and upper 95%
conﬁdence intervals that were computed by the proﬁle likelihood. B. Two-sided
binominal test (p-value) as a function of time, comparing adjusted CFR against
published values, 20% and 40%. The horizontal dashed grey line corresponds to the
threshold value (5%).
K. Mizumoto et al. / International Journal of Infectious Diseases 39 (2015) 7–98Conﬁrmed diagnosis was made based on laboratory diagnosis by
detecting viral nucleic acid or serological test, regardless of the
presence of clinical signs and symptoms.
For the estimation of the CFR in real time, we employed an
integral equation model, the mathematical details of which were
described elsewhere.14,15 To adjust the right censoring, the time of
illness onset to death was assumed to follow a gamma distribution,
fs, with the median of 11 days, and the coefﬁcient of variation was
assumed at 50.0%.16 Maximum likelihood estimate of the CFR was
obtained by adjusting the time delay from illness onset to death,
and the 95% conﬁdence interval (CI) was computed by using the
proﬁle likelihood. To test the difference between the estimate in
the Republic of Korea against published two estimates, i.e.,
pref=0.20 and 0.40, a two-sided binomial test was employed. The
level of statistical signiﬁcance was set to be a=0.05.
3. Results
Cumulative numbers of cases and deaths are illustrated in
Figure 1. An increase in the number of deaths is delayed as
compared to that in cases. Figure 2 A and 2B show the estimates of
the risk of death using the abovementioned method. The most recent
estimate of the CFR in the Republic of Korea appeared to be 20.0%
(95% CI: 14.6, 26.2). During the course of the outbreak, the crude
ratios of deaths to cases without accounting for the time delay from
illness onset to death was smaller than our delay-adjusted estimates
(Figure 2A). Estimate of the CFR in real time appeared to have
decreased and become signiﬁcantly lower than 40% (Figure 2B). The
most up-to-date CFR among those aged 60 years or older was
estimated at 39.5% (95% CI: 28.9, 51.0), while that among those aged
from 0-59 years was as small as 6.6% (95% CI: 2.9, 12.4).
4. Discussion
The present study estimated the CFR for the ongoing MERS
outbreak in the Republic of Korea. Using the most up-to-date data,
the CFR was estimated at 20.0% (95% CI: 14.6, 26.2), which was not
signiﬁcantly different from 20%, agreeing estimates among
secondary cases in literature.8,9,17 The obtained value in real time
was greater than that calculated from the crude ratio of deaths toFigure 1. Temporal distribution of cases and deaths due to Middle East respiratory
syndrome coronavirus (MERS-CoV) in the Republic of Korea, 2015.
Cumulative numbers of cases (A) and deaths (B) over time. As the dates of illness
onset were not fully available from the midst of outbreak, we partially used dates of
conﬁrmatory diagnosis for a part of cases (white bars in panel A). Suspicious
symptoms of contacts under observation have been closely monitored, and traced
suspected cases have been consistently tested during the course of the outbreak.cases, which could have indicated that the risk of death was as
small as below 10% during the course of the outbreak. Govern-
ments and public health agencies are advised to adopt the
suggested method during the real-time announcement of emerg-
ing outbreaks.5,14
The estimated CFR during the early epidemic phase was
consistent with 40%, but the estimate has declined over the course
of the epidemic. There can be two possible explanations. First, in
the Republic of Korea, extensive contact tracing and quarantine
have been carried out.10,11,18,19. Thus, while our estimate of the CFR
was initially consistent with 40% (e.g. in mid-June in Figure 2A),
ascertainment rate in Korea could have been improved over time,
and increased diagnostic coverage may have been reﬂected in the
CFR estimate during the latter half stage of this outbreak. Second,
we have found that the CFR among elderly persons age 60 years or
older was as high as 40%, while that among younger individuals
was as low as 7%. As an underlying mechanism of the time-
dependent decrease in the CFR, our estimate of the CFR in Korea
may have been sensitive to the fraction of cases with comorbid-
ities. That is, if the early cluster of cases represents elderly with
underlying comorbidity which has transmitted the disease to
healthier individuals in the later stage of the outbreak, that could
partly explain why the estimated CFR decreased over time.
In conclusion, the risk of MERS death in the Republic of Korea
has been shown to be consistent with 20%. Estimation of the CFR
has to account for the time delay from illness onset to death.
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